In a model of diabetes induced by fructose and streptozotocin in CD-1 mice, SGLT2 inhibitors (empagliflozin and dapagliflozin) contributed to the multifactorial neuroprotection [38]. Here, SLC5A2 is linked to diabetes mellitus.